Cargando…

Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy

BACKGROUND/AIMS: To evaluate the impact of isoniazid (INH) treatment for latent tuberculosis infection (LTBI) on the development of liver function test (LFT) abnormality and the persistence of tumor necrosis factor (TNF) inhibitors in rheumatoid arthritis (RA) patients. METHODS: We retrospectively e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Yoon-Kyoung, Cho, Soo-Kyung, Kim, Dam, Won, Soyoung, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Yoo, Dae-Hyun, Bae, Sang-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129622/ https://www.ncbi.nlm.nih.gov/pubmed/28288508 http://dx.doi.org/10.3904/kjim.2016.214

Ejemplares similares

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016)

Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis
por: Cho, Soo-Kyoung, et al.
Publicado: (2019)

Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
por: Son, Chang-Nam, et al.
Publicado: (2014)

Factors associated with selection of targeted therapy in patients with rheumatoid arthritis
por: Song, Yeo-Jin, et al.
Publicado: (2023)

Injectable Gold-Induced Hepatitis and Neutropenia in Rheumatoid Arthritis
por: Uhm, Wan-Sik, et al.
Publicado: (2000)

Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study
por: Song, Yeo-Jin, et al.
Publicado: (2021)

Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case–control study
por: Song, Yeo-Jin, et al.
Publicado: (2022)

Impact of early diagnosis on functional disability in rheumatoid arthritis
por: Kim, Dam, et al.
Publicado: (2017)

The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis
por: Lee, Joo-Hyun, et al.
Publicado: (2016)

Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
por: Song, Yeo-Jin, et al.
Publicado: (2023)

Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid
por: de Oyarzabal, Eleane, et al.
Publicado: (2019)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Undifferentiated spondyloarthropathy in Korea: focusing on peripheral arthritis.
por: Kim, Tae Hwan, et al.
Publicado: (2002)

Korean Red Ginseng exhibits no significant adverse effect on disease activity in patients with rheumatoid arthritis: a randomized, double-blind, crossover study
por: Cho, Soo-Kyung, et al.
Publicado: (2018)

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis
por: Gu, Ki-Nam, et al.
Publicado: (2019)

Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort
por: Kim, Hyoungyoung, et al.
Publicado: (2023)

Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis
por: Kim, Kwangwoo, et al.
Publicado: (2016)

MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations
por: Joo, Young Bin, et al.
Publicado: (2022)

Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Kim, Kwangwoo, et al.
Publicado: (2016)

Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2016)

The Effect of Leflunomide on Cold and Vibratory Sensation in Patients with Rheumatoid Arthritis
por: Kim, Hyung Kuk, et al.
Publicado: (2012)

Higher prevalence of peripheral arthritis among ankylosing spondylitis patients.
por: Lee, Ji-Hyun, et al.
Publicado: (2002)

Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis
por: Kwon, Young-Chang, et al.
Publicado: (2020)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Epigenetic analysis in rheumatoid arthritis synoviocytes
por: Ham, Seokjin, et al.
Publicado: (2019)

Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
por: Lee, Joo-Hyun, et al.
Publicado: (2014)

Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis
por: Torres, Martha, et al.
Publicado: (2015)

1694 Risk factors and outcomes of isoniazid hepatotoxicity in children with latent tuberculosis
por: Devrim, Ilker, et al.
Publicado: (2014)

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
por: Yu, Ya-Yen, et al.
Publicado: (2019)

Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients
por: Mehta, Bella, et al.
Publicado: (2015)

Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
por: Lai, Wendy A., et al.
Publicado: (2022)

Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?
por: Navalkele, Bhagyashri, et al.
Publicado: (2020)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
por: Ilaiwy, Ghassan, et al.
Publicado: (2021)

Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis
por: Oscanoa, Teodoro J., et al.
Publicado: (2023)

Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study
por: Nam, Bora, et al.
Publicado: (2021)

Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
por: Liou, Bo‐Huang, et al.
Publicado: (2021)

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA
por: Jeong, Dae Hyun, et al.
Publicado: (2018)

A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
por: Philipose, Jobin, et al.
Publicado: (2022)

Diagnosis and Treatment of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists in Korea
por: Yun, Jong Wook, et al.
Publicado: (2007)

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nfojukr35v84a1iv9qtdm301v9